Annual Review of Genomics and Human Genetics, published by ANNUAL REVIEWS, represents a pivotal platform in the field of Genetics and Molecular Biology. With an impressive impact factor reflecting its high citation rate and scholarly influence, this journal is renowned for its authoritative reviews that synthesize current research across genomics and human genetics. Highlighting its Q1 category rankings in both Genetics and Clinical Genetics, as well as its ranking within the top tiers of Biochemistry and Genetics, the journal stands out as a leading resource for researchers, professionals, and students eager to stay abreast of groundbreaking developments in these rapidly evolving fields. While not currently an open access journal, its rigorous peer-review process ensures the highest standards of scientific integrity. Researchers can access comprehensive reviews that delve into both fundamental genetics concepts and cutting-edge discoveries, making it an essential resource for advancing understanding in human genetics and its applications.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS is a premier peer-reviewed journal published by Wiley, focusing on the intricate and evolving field of medical genetics. With its ISSN 1552-4868 and E-ISSN 1552-4876, the journal has established itself as a significant resource for researchers, professionals, and students alike, addressing cutting-edge developments in genetic research and clinical practice. Ranked in the top quartile (Q2) in both Genetics and clinical Genetics categories for 2023, it maintains an impressive Scopus ranking, positioning it within the 75th and 71st percentiles for Medicine and Genetics respectively. The journal encourages open access to its content, promoting wider dissemination of knowledge and fostering collaboration among medical genetics experts. From its inaugural issues in 1980 to its ongoing publications, the journal aims to bridge the gap between genetics research and its clinical applications, providing insights that reflect the latest advancements in the field. As it continues to serve the global medical community, the AMERICAN JOURNAL OF MEDICAL GENETICS PART C remains a vital source for those seeking to understand the complexities of genetic disorders and their implications for health and disease.

Application of Clinical Genetics is a premier open-access journal published by Dove Medical Press Ltd., dedicated to advancing the field of clinical genetics since its inception in 2008. Based in New Zealand, this journal has established itself as a significant resource for researchers, clinicians, and students alike, contributing to the body of knowledge in both genetic medicine and clinical applications. With an impact factor reflecting its contributions to the field, the journal holds positions in the Q2 and Q3 quartiles of the 2023 Genetics categories, showcasing its relevance and scientific merit. Furthermore, it ranks #43 out of 99 in Clinical Genetics and #153 out of 347 in Biochemistry, Genetics, and Molecular Biology, indicating robust performance amongst its peers. The journal’s broad scope, encompassing various aspects of clinical genetics, ensures that it remains at the forefront of critical discussions, innovative research, and applications essential for the progression of personalized medicine. Researchers and professionals are encouraged to explore its openly accessible content that fosters collaboration and the sharing of knowledge in this dynamic and rapidly evolving field.

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Balkan Journal of Medical Genetics is an esteemed scientific publication dedicated to advancing research in the field of medical genetics. Established in 2000 and published by SCIENDO, the journal has embraced an Open Access model since 2007, ensuring that vital findings are readily accessible to researchers, healthcare professionals, and students worldwide. With an ISSN of 1311-0160 and an E-ISSN of 2199-5761, this journal serves as a platform for innovative studies and clinical findings, although it currently ranks in the lower quartiles within its categories according to the 2023 Scopus rankings. The journal's geographical roots in Macedonia reflect the region's commitment to contributing to the global understanding of genetics. By publishing high-quality research, the Balkan Journal of Medical Genetics aims to foster collaboration and knowledge exchange among scientists and healthcare providers, ultimately enhancing patient care and genetic research practices.

RUSSIAN JOURNAL OF GENETICS is a significant platform in the field of genetics, published by PLEIADES PUBLISHING INC since its inception in 1996. With an ISSN of 1022-7954 and an E-ISSN of 1608-3369, the journal focuses on a wide array of topics within genetics, providing researchers, professionals, and students with insights into advancements and discoveries in this ever-evolving discipline. While it currently holds a Q4 ranking in the 2023 Genetics category according to Scopus, representing invaluable opportunities for knowledge dissemination, the journal is actively working to enhance its impact in future rankings. Readers will find the journal a repository of diverse genetic research findings, methodologies, and theoretical advancements. Although it is not an open-access journal, it is committed to serving the academic community through rigorous peer-reviewed articles. With a consistent publication trajectory spanning to 2024, the RUSSIAN JOURNAL OF GENETICS remains a crucial resource for those aspiring to stay at the forefront of genetic research and applications.

The Egyptian Journal of Medical Human Genetics is a distinguished Open Access journal published by SPRINGER NATURE, dedicated to advancing the field of medical human genetics. With an ISSN of 1110-8630 and an E-ISSN of 2090-2441, this journal serves as a vital platform for researchers, professionals, and students who are committed to the exploration of genetic implications on human health. Since its inception in 2010, it has become a growing repository of knowledge, significantly contributing to the discourse in clinical genetics, despite currently being ranked in the Q4 quartile of its category in 2023. The journal embraces an open access model, ensuring widespread visibility and accessibility of published research, thereby fostering collaboration and innovation in the field. The journal is not only aimed at disseminating findings but also at encouraging the dialogue around genetic research developments, making it an essential resource for anyone interested in the nuances of genetics and its impact on medicine.

JOURNAL OF GENETICS, published by the Indian Academy of Sciences, is a pivotal platform for researchers and scholars in the field of genetics. With its long-standing history dating back to 1910, this journal has consistently contributed to the academic discourse through the rigorous publication of original research, reviews, and case studies. Despite its current classification in the Q4 quartile for the 2023 metrics in Genetics, the journal plays a critical role in advancing our understanding of genetic principles, experimental methodologies, and innovations. Spanning a diverse array of topics, the journal aims to foster scholarly exchange and collaboration within the global genetics community. For researchers aiming to publish their work, accessing the journal’s comprehensive archives, which include publications from as early as 1910 to the present day, offers a valuable perspective on the evolution of genetic research. As it continues to adapt to the changing landscape of scientific inquiry, JOURNAL OF GENETICS remains a significant resource for students, professionals, and academics dedicated to exploring the complexities of genetics.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.